Vanita R. Aroda

Semaglutide versus dulaglutide once weekly in patients with type 2 diabetes (SUSTAIN 7): a randomised, open-label, phase 3b trial

Richard E. Pratley, Vanita R. Aroda, Ildiko Lingvay et al. · The Lancet Diabetes & Endocrinology · 2018 · 714 citations

Metabolic Syndrome, Diabetes Management, Diabetes +9

Vitamin D Supplementation and Prevention of Type 2 Diabetes

Anastassios G. Pittas, Bess Dawson‐Hughes, Patricia Sheehan et al. · New England Journal of Medicine · 2019 · 626 citations · Full text

Efficacy and Safety of Once-Weekly Semaglutide Versus Exenatide ER in Subjects With Type 2 Diabetes (SUSTAIN 3): A 56-Week, Open-Label, Randomized Clinical Trial

Andrew Ahmann, Matthew Capehorn, G. Charpentier et al. · Diabetes Care · 2017 · 542 citations

Long-term Metformin Use and Vitamin B12 Deficiency in the Diabetes Prevention Program Outcomes Study

Vanita R. Aroda, Sharon L. Edelstein, Ronald Goldberg et al. · The Journal of Clinical Endocrinology & Metabolism · 2016 · 496 citations · Full text

The Effect of Lifestyle Intervention and Metformin on Preventing or Delaying Diabetes Among Women With and Without Gestational Diabetes: The Diabetes Prevention Program Outcomes Study 10-Year Follow-Up

Vanita R. Aroda, Costas A. Christophi, Sharon L. Edelstein et al. · The Journal of Clinical Endocrinology & Metabolism · 2015 · 451 citations · Full text